• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙网蛋白增强B2缓激肽受体的成熟和异源二聚化。

Calreticulin enhances B2 bradykinin receptor maturation and heterodimerization.

作者信息

Abd Alla Joshua, Reeck Kristin, Langer Andreas, Streichert Thomas, Quitterer Ursula

机构信息

Department of Molecular Pharmacology, Swiss Federal Institute of Technology and University of Zurich, Winterthurerstrasse 190, Zurich, Switzerland.

出版信息

Biochem Biophys Res Commun. 2009 Sep 11;387(1):186-90. doi: 10.1016/j.bbrc.2009.07.011. Epub 2009 Jul 4.

DOI:10.1016/j.bbrc.2009.07.011
PMID:19580784
Abstract

In different native tissues and cells the receptor for the vasodepressor bradykinin, B(2), forms dimers with the receptor for the vasopressor angiotensin II, AT(1). Because AT(1)/B(2) heterodimers may contribute to enhanced angiotensin II-stimulated signaling under pathophysiological conditions, we analyzed mechanisms of AT(1)/B(2) heterodimerization. We found that efficient B(2) receptor maturation was a prerequisite for heterodimerization because only the fully mature B(2) receptor was capable to interact with AT(1). To identify chaperones involved in B(2) receptor maturation and heterodimerization we performed microarray gene expression profiling of human embryonic kidney (HEK293) cells. The expression of the chaperone calreticulin was up-regulated in cells with efficient B(2) receptor maturation. Vice versa, upon down regulation of calreticulin expression by RNA interference, B(2) receptor maturation and AT(1)/B(2) receptor heterodimerization were significantly impaired. Concomitantly, the B(2) receptor-mediated enhancement of AT(1)-stimulated signaling was reduced. Thus, calreticulin enhances B(2) receptor maturation and heterodimerization with AT(1).

摘要

在不同的天然组织和细胞中,血管舒张肽缓激肽的受体B(2)与血管收缩肽血管紧张素II的受体AT(1)形成二聚体。由于在病理生理条件下,AT(1)/B(2)异源二聚体可能有助于增强血管紧张素II刺激的信号传导,我们分析了AT(1)/B(2)异源二聚化的机制。我们发现,有效的B(2)受体成熟是异源二聚化的先决条件,因为只有完全成熟的B(2)受体才能与AT(1)相互作用。为了鉴定参与B(2)受体成熟和异源二聚化的伴侣蛋白,我们对人胚肾(HEK293)细胞进行了微阵列基因表达谱分析。在B(2)受体有效成熟的细胞中,伴侣蛋白钙网蛋白的表达上调。反之,通过RNA干扰下调钙网蛋白的表达后,B(2)受体成熟和AT(1)/B(2)受体异源二聚化受到显著损害。同时,B(2)受体介导的AT(1)刺激信号增强也降低。因此,钙网蛋白增强了B(2)受体的成熟以及与AT(1)的异源二聚化。

相似文献

1
Calreticulin enhances B2 bradykinin receptor maturation and heterodimerization.钙网蛋白增强B2缓激肽受体的成熟和异源二聚化。
Biochem Biophys Res Commun. 2009 Sep 11;387(1):186-90. doi: 10.1016/j.bbrc.2009.07.011. Epub 2009 Jul 4.
2
Establishment of an in vivo model facilitates B2 receptor protein maturation and heterodimerization.建立体内模型有助于 B2 受体蛋白的成熟和异二聚化。
Integr Biol (Camb). 2010 Apr;2(4):209-17. doi: 10.1039/b922592g. Epub 2010 Mar 15.
3
Vasopressor meets vasodepressor: The AT1-B2 receptor heterodimer.血管加压素遇见血管舒张素:AT1-B2 受体异二聚体。
Biochem Pharmacol. 2014 Apr 1;88(3):284-90. doi: 10.1016/j.bcp.2014.01.019. Epub 2014 Jan 22.
4
A cleavable signal peptide enhances cell surface delivery and heterodimerization of Cerulean-tagged angiotensin II AT1 and bradykinin B2 receptor.可切割信号肽增强 Cerulean 标记的血管紧张素 II AT1 和缓激肽 B2 受体的细胞表面递呈和异二聚化。
Biochem Biophys Res Commun. 2011 Jun 10;409(3):544-9. doi: 10.1016/j.bbrc.2011.05.041. Epub 2011 May 11.
5
Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness.子痫前期中增加的AT(1)受体异二聚体介导了增强的血管紧张素II反应性。
Nat Med. 2001 Sep;7(9):1003-9. doi: 10.1038/nm0901-1003.
6
Angiotensin II type 1 and bradykinin B2 receptors expressed in early stage epithelial cells derived from human embryonic stem cells.血管紧张素II 1型受体和缓激肽B2受体在源自人类胚胎干细胞的早期上皮细胞中表达。
J Cell Physiol. 2007 Jun;211(3):816-25. doi: 10.1002/jcp.20985.
7
EP24.15 interacts with the angiotensin II type I receptor and bradykinin B2 receptor.EP24.15与血管紧张素II 1型受体和缓激肽B2受体相互作用。
Cell Biochem Funct. 2005 May-Jun;23(3):195-204. doi: 10.1002/cbf.1176.
8
AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration.血管紧张素Ⅱ1型受体异二聚体表现出增强的G蛋白激活和改变的受体隔离。
Nature. 2000 Sep 7;407(6800):94-8. doi: 10.1038/35024095.
9
Renal gene expression profiling using kinin B1 and B2 receptor knockout mice reveals comparable modulation of functionally related genes.使用缓激肽B1和B2受体基因敲除小鼠进行的肾脏基因表达谱分析揭示了功能相关基因的类似调节。
Biol Chem. 2006 Jan;387(1):15-22. doi: 10.1515/BC.2006.004.
10
Regulation of kinin B(2) receptors by bradykinin in human lung cells.缓激肽对人肺细胞中缓激肽B(2)受体的调节作用
Biol Chem. 2008 Nov;389(11):1435-40. doi: 10.1515/BC.2008.159.

引用本文的文献

1
Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor.血管紧张素 II 型受体和缓激肽 B2 型受体异源二聚化后的新型药理学
Front Endocrinol (Lausanne). 2022 May 26;13:848816. doi: 10.3389/fendo.2022.848816. eCollection 2022.
2
Discovery of Pathologic GPCR Aggregation.病理性G蛋白偶联受体聚集的发现
Front Med (Lausanne). 2019 Jan 30;6:9. doi: 10.3389/fmed.2019.00009. eCollection 2019.
3
Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.
血管紧张素 II 型 1 型受体研究的当前热点:关注反向激动剂、受体二聚化和偏向激动作用。
Pharmacol Res. 2017 Sep;123:40-50. doi: 10.1016/j.phrs.2017.06.013. Epub 2017 Jun 23.
4
Heteromerization Between the Bradykinin B2 Receptor and the Angiotensin-(1-7) Mas Receptor: Functional Consequences.缓激肽B2受体与血管紧张素-(1-7) Mas受体之间的异源二聚化:功能后果
Hypertension. 2016 Oct;68(4):1039-48. doi: 10.1161/HYPERTENSIONAHA.116.07874. Epub 2016 Aug 22.
5
The serine protease hepsin mediates urinary secretion and polymerisation of Zona Pellucida domain protein uromodulin.丝氨酸蛋白酶海普辛介导尿调节素(一种透明带结构域蛋白)的尿液分泌和聚合。
Elife. 2015 Dec 17;4:e08887. doi: 10.7554/eLife.08887.
6
G Protein-Coupled Receptor Heteromers.G蛋白偶联受体异聚体
Annu Rev Pharmacol Toxicol. 2016;56:403-25. doi: 10.1146/annurev-pharmtox-011613-135952. Epub 2015 Oct 22.
7
High-frequency stimulation of the subthalamic nucleus counteracts cortical expression of major histocompatibility complex genes in a rat model of Parkinson's disease.在帕金森病大鼠模型中,高频刺激丘脑底核可对抗主要组织相容性复合体基因的皮质表达。
PLoS One. 2014 Mar 12;9(3):e91663. doi: 10.1371/journal.pone.0091663. eCollection 2014.
8
Application of G protein-coupled receptor-heteromer identification technology to monitor β-arrestin recruitment to G protein-coupled receptor heteromers.应用G蛋白偶联受体异聚体鉴定技术监测β-抑制蛋白募集至G蛋白偶联受体异聚体。
Assay Drug Dev Technol. 2011 Feb;9(1):21-30. doi: 10.1089/adt.2010.0336. Epub 2010 Dec 6.
9
Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.血管紧张素转化酶抑制作用下调促动脉粥样硬化趋化因子受体 9(CCR9)-趋化因子配体 25(CCL25)轴。
J Biol Chem. 2010 Jul 23;285(30):23496-505. doi: 10.1074/jbc.M110.117481. Epub 2010 May 26.